• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光学相干断层扫描测量的视盘周围视网膜神经纤维层不仅是多发性硬化症身体残疾进展的预后生物标志物,也是认知残疾进展的预后生物标志物。

Peripapillary retinal nerve fibre layer as measured by optical coherence tomography is a prognostic biomarker not only for physical but also for cognitive disability progression in multiple sclerosis.

机构信息

Clinical Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

Department of Ophthalmology, Medical University of Innsbruck, Innsbruck, Austria.

出版信息

Mult Scler. 2019 Feb;25(2):196-203. doi: 10.1177/1352458517740216. Epub 2017 Nov 2.

DOI:10.1177/1352458517740216
PMID:29095097
Abstract

BACKGROUND

Peripapillary retinal nerve fibre layer (pRNFL) thickness is emerging as a marker of axonal degeneration in multiple sclerosis (MS).

OBJECTIVE

We aimed to prospectively assess the predictive value of pRNFL for progression of physical and cognitive disability in relapsing-remitting MS (RRMS).

METHODS

In this 3-year longitudinal study on 151 RRMS patients, pRNFL was measured by spectral-domain optical coherence tomography (OCT). We used proportional hazard models, correcting for age, sex, disease duration, Expanded Disability Status Scale (EDSS) and Symbol Digit Modalities Test (SDMT) at baseline, to test a pRNFL thickness ≤88 µm at baseline for prediction of EDSS progression and cognitive decline. We also evaluated the decrease in pRNFL thickness from baseline to year 3 in a multivariate linear regression model.

RESULTS

pRNFL thickness ≤88 µm was independently associated with a threefold increased risk of EDSS progression ( p < 0.001) and a 2.7-fold increased risk of cognitive decline within the subsequent 3 years ( p < 0.001). Mean pRNFL delta was -5.3 µm (SD, 4.2). It was significantly negatively impacted by EDSS progression, cognitive decline, higher age and disease duration, while positively impacted by disease-modifying therapy (DMT).

CONCLUSION

Cross-sectional and longitudinal monitoring of pRNFL is useful as a biomarker for prediction of physical and cognitive disability progression in patients with RRMS in everyday clinical practice.

摘要

背景

视盘周围视网膜神经纤维层(pRNFL)厚度已成为多发性硬化症(MS)轴突退变的标志物。

目的

我们旨在前瞻性评估 pRNFL 对复发缓解型多发性硬化症(RRMS)患者身体和认知功能障碍进展的预测价值。

方法

在这项对 151 例 RRMS 患者进行的 3 年纵向研究中,采用频域光学相干断层扫描(OCT)测量 pRNFL。我们使用比例风险模型,校正年龄、性别、疾病持续时间、基线扩展残疾状况量表(EDSS)和符号数字模态测试(SDMT),以检验基线时 pRNFL 厚度≤88μm 预测 EDSS 进展和认知下降的情况。我们还在多元线性回归模型中评估了基线到第 3 年 pRNFL 厚度的下降情况。

结果

基线时 pRNFL 厚度≤88μm 与 EDSS 进展风险增加三倍相关(p<0.001),与随后 3 年内认知下降风险增加 2.7 倍相关(p<0.001)。pRNFL 平均下降值为-5.3μm(标准差 4.2)。它与 EDSS 进展、认知下降、较高的年龄和疾病持续时间呈显著负相关,与疾病修正治疗(DMT)呈显著正相关。

结论

在日常临床实践中,pRNFL 的横断面和纵向监测可作为 RRMS 患者身体和认知功能障碍进展预测的生物标志物。

相似文献

1
Peripapillary retinal nerve fibre layer as measured by optical coherence tomography is a prognostic biomarker not only for physical but also for cognitive disability progression in multiple sclerosis.光学相干断层扫描测量的视盘周围视网膜神经纤维层不仅是多发性硬化症身体残疾进展的预后生物标志物,也是认知残疾进展的预后生物标志物。
Mult Scler. 2019 Feb;25(2):196-203. doi: 10.1177/1352458517740216. Epub 2017 Nov 2.
2
Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study.光学相干断层扫描测量的视网膜厚度与多发性硬化症残疾恶化风险:一项队列研究。
Lancet Neurol. 2016 May;15(6):574-84. doi: 10.1016/S1474-4422(16)00068-5. Epub 2016 Mar 18.
3
Peripapillary retinal nerve fibre layer thinning rate as a biomarker discriminating stable and progressing relapsing-remitting multiple sclerosis.视盘周围视网膜神经纤维层变薄率作为鉴别稳定和进展复发缓解型多发性硬化症的生物标志物。
Eur J Neurol. 2019 Jun;26(6):865-871. doi: 10.1111/ene.13897. Epub 2019 Feb 19.
4
Retinal nerve fiber layer thickness associates with cognitive impairment and physical disability in multiple sclerosis.视网膜神经纤维层厚度与多发性硬化症患者的认知障碍和身体残疾有关。
Mult Scler Relat Disord. 2019 Nov;36:101414. doi: 10.1016/j.msard.2019.101414. Epub 2019 Sep 26.
5
Optical coherence tomography in multiple sclerosis: A 3-year prospective multicenter study.光学相干断层扫描在多发性硬化症中的应用:一项为期 3 年的前瞻性多中心研究。
Ann Clin Transl Neurol. 2021 Dec;8(12):2235-2251. doi: 10.1002/acn3.51473. Epub 2021 Nov 18.
6
Optical coherence tomography segmentation analysis in relapsing remitting versus progressive multiple sclerosis.复发缓解型与进展型多发性硬化症的光学相干断层扫描分割分析
PLoS One. 2017 Feb 13;12(2):e0172120. doi: 10.1371/journal.pone.0172120. eCollection 2017.
7
Peripapillary retinal nerve fiber layer thickness measured by optical coherence tomography in different clinical subtypes of multiple sclerosis.光学相干断层扫描测量多发性硬化不同临床亚型的视盘周围视网膜神经纤维层厚度。
Mult Scler Relat Disord. 2019 Jan;27:260-268. doi: 10.1016/j.msard.2018.11.003. Epub 2018 Nov 5.
8
Retinal nerve fiber layer thickness and neurologic disability in relapsing-remitting multiple sclerosis.复发缓解型多发性硬化症患者的视网膜神经纤维层厚度与神经功能障碍
J Neurol Sci. 2015 Dec 15;359(1-2):305-8. doi: 10.1016/j.jns.2015.11.017. Epub 2015 Nov 10.
9
Evolution of retinal degeneration and prediction of disease activity in relapsing and progressive multiple sclerosis.视网膜变性的演变与复发进展性多发性硬化症疾病活动的预测。
Nat Commun. 2024 Jun 19;15(1):5243. doi: 10.1038/s41467-024-49309-7.
10
Relationship Between Retinal Layer Thickness and Disability Worsening in Relapsing-Remitting and Progressive Multiple Sclerosis.视网膜层厚度与复发缓解型和进展型多发性硬化残疾恶化的关系。
J Neuroophthalmol. 2021 Sep 1;41(3):329-334. doi: 10.1097/WNO.0000000000001165.

引用本文的文献

1
Optical coherence tomography - A possible biomarker in early huntington's disease.光学相干断层扫描——早期亨廷顿舞蹈病的一种潜在生物标志物。
Neurol Res Pract. 2025 Aug 28;7(1):61. doi: 10.1186/s42466-025-00421-z.
2
Retinal Optical Coherence Tomography Longitudinal Measures as Prognostic Biomarkers in Multiple Sclerosis: Systematic Review and Meta-Analysis.视网膜光学相干断层扫描纵向测量作为多发性硬化症的预后生物标志物:系统评价和荟萃分析
Neurol Neuroimmunol Neuroinflamm. 2025 Jul;12(4):e200416. doi: 10.1212/NXI.0000000000200416. Epub 2025 May 27.
3
The Effects of Disease-Modifying Therapies on Optic Nerve Degeneration in Multiple Sclerosis.
疾病修饰疗法对多发性硬化症视神经变性的影响。
Eur J Neurol. 2025 Mar;32(3):e70081. doi: 10.1111/ene.70081.
4
Optical coherence tomography in secondary progressive multiple sclerosis: cross-sectional and longitudinal exploratory analysis from the MS-SMART randomised controlled trial.光学相干断层扫描在继发进展型多发性硬化症中的应用:来自MS-SMART随机对照试验的横断面和纵向探索性分析
J Neurol Neurosurg Psychiatry. 2025 Jun 12;96(7):647-654. doi: 10.1136/jnnp-2024-334801.
5
Retinal thinning differentiates treatment effects in relapsing multiple sclerosis below the clinical threshold.视网膜变薄可区分复发型多发性硬化症低于临床阈值的治疗效果。
Ann Clin Transl Neurol. 2025 Feb;12(2):345-354. doi: 10.1002/acn3.52279. Epub 2024 Dec 16.
6
Paramagnetic rim lesions are associated with inner retinal layer thinning and progression independent of relapse activity in multiple sclerosis.顺磁性边缘病变与多发性硬化症中视网膜内层变薄及病情进展相关,且与复发活动无关。
Eur J Neurol. 2025 Jan;32(1):e16529. doi: 10.1111/ene.16529. Epub 2024 Nov 12.
7
Evolution of retinal degeneration and prediction of disease activity in relapsing and progressive multiple sclerosis.视网膜变性的演变与复发进展性多发性硬化症疾病活动的预测。
Nat Commun. 2024 Jun 19;15(1):5243. doi: 10.1038/s41467-024-49309-7.
8
De-escalation of Disease-Modifying Therapy for People with Multiple Sclerosis Due to Safety Considerations: Characterizing 1-Year Outcomes in 25 People Who Switched from Ocrelizumab to Diroximel Fumarate.由于安全性考虑对多发性硬化症患者进行疾病修饰疗法的降级:25 名从奥瑞珠单抗转换为富马酸二甲酯的患者在 1 年的结局特征。
Adv Ther. 2024 Aug;41(8):3059-3075. doi: 10.1007/s12325-024-02902-0. Epub 2024 Jun 11.
9
Odour discrimination and identification as a biomarker of long-term disability worsening in multiple sclerosis.气味辨别和识别作为多发性硬化长期残疾恶化的生物标志物。
Mult Scler. 2024 Jan;30(1):55-62. doi: 10.1177/13524585231201093. Epub 2023 Oct 18.
10
Optical coherence tomography versus other biomarkers: Associations with physical and cognitive disability in multiple sclerosis.光学相干断层扫描与其他生物标志物:与多发性硬化症的身体和认知残疾的关联。
Mult Scler. 2023 Nov;29(13):1540-1550. doi: 10.1177/13524585231198760. Epub 2023 Sep 29.